Dr. Mallbris is the vice president of global immunology development and medical affairs at Eli Lilly and Company. At Lilly, she is working to improve the lives of millions of people with autoimmune diseases by furthering innovation in health care and solving problems for patients. Dr. Mallbris is a passionate executive leader who brings a unique perspective to the industry as she began her career as a trained physician and has diverse experience across the spectrums of patient care, academic research, pharmaceutical drug development and global medical affairs.

She joined Lilly in 2015 and leads the company’s multifunctional Global Clinical Development and Global Medical Affairs teams across the dermatology, rheumatology, and gastroenterology fields. Before joining Lilly, she spent several years at Pfizer and held leadership positions within the dermatology business. Prior to joining the corporate world, Dr. Mallbris was a practicing physician for more than 10 years, starting her career as a surgeon before transitioning to the field of dermatology. Her decision to shift from academia and practicing as a dermatologist to joining a biopharmaceutical company was rooted in her desire to help more patients and bring them the treatments they need.

Dr. Mallbris has always been devoted to patients and found caring for them incredibly rewarding, but recognized an opportunity to take that devotion to the next level by joining the companies working to create the innovative solutions needed to help patients around the world. She continues to be an active member of multiple external immunology research advisory boards that focus on public health and epidemiology, bridging the external state-of-the-art research with Lilly.